Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 2,894,012 |
|
|||||
| News | (1) | ||||||
| Day High | 123.50 | Low High |
|||||
| Day Low | 118.68 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -1.18 | -0.97% | 120.95 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 122.86 | 118.68 | 123.50 | 121.07 | 122.13 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 50,793 | 2,894,012 | $ 120.72 | $ 349,366,778 | - | 62.55 - 142.79 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:49 | 1 | $ 120.90 | USD |
Moderna (MRNA) Options Flow Summary
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 46.26B | 382.07M | - | 6.85B | -4.71B | -12.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 110.50 | 128.81 | 109.00 | 121.24 | 5,496,166 | 10.45 | 9.46% |
| 1 Month | 105.90 | 128.81 | 99.30 | 112.45 | 3,632,969 | 15.05 | 14.21% |
| 3 Months | 86.81 | 128.81 | 84.06 | 104.26 | 3,901,813 | 34.14 | 39.33% |
| 6 Months | 72.18 | 128.81 | 67.62 | 97.24 | 4,300,619 | 48.77 | 67.57% |
| 1 Year | 136.24 | 142.79 | 62.55 | 102.24 | 4,077,557 | -15.29 | -11.22% |
| 3 Years | 165.69 | 497.17 | 62.55 | 220.27 | 6,883,023 | -44.74 | -27.00% |
| 5 Years | 27.18 | 497.17 | 11.54 | 147.49 | 8,850,624 | 93.77 | 345.00% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
